Paper Details
- Home
- Paper Details
Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid.
Author: Aghazadeh-HabashiAli, AsgharWaheed, JamaliFakhreddin
Original Abstract of the Article :
Inflammatory conditions increase cardiovascular (CV) risk. Some nonsteroidal anti-inflammatory drugs (NSAIDs) that are used to treat pain and inflammation are also associated with CV complications. Inflammation, but not NSAIDs, disrupts the balance of vasodilator and vasoconstrictor components of th...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.xphs.2017.09.020
データ提供:米国国立医学図書館(NLM)
The Impact of Inflammation and NSAIDs on Arachidonic Acid Metabolism
This study delves into the intricate relationship between inflammation, nonsteroidal anti-inflammatory drugs (NSAIDs), and the metabolism of arachidonic acid (ArA), a key player in the inflammatory process. The research focuses on how inflammation and different NSAIDs affect the balance of ArA metabolites, which play crucial roles in cardiovascular health.
NSAIDs Can Disrupt the Balance of ArA Metabolites
The study revealed that inflammation, particularly in the context of adjuvant arthritis, disrupted the balance of ArA metabolites, leading to an increase in the ratio of cardiotoxic 20-hydroxyeicosatetraenoic acid to cardioprotective epoxyeicosatrienoic acids in the heart. Rofecoxib, an NSAID with known cardiotoxicity, further exacerbated this imbalance. These findings suggest that NSAIDs can differentially impact ArA metabolism, potentially influencing cardiovascular risk.
Potential Implications for Cardiovascular Safety
This research highlights the importance of considering the impact of NSAIDs on ArA metabolism when assessing their cardiovascular safety. The findings suggest that specific NSAIDs, such as rofecoxib, might be associated with a greater risk of cardiovascular complications due to their influence on ArA metabolism. This information is crucial for guiding the selection of NSAIDs for patients, particularly those at increased risk for cardiovascular disease.
Dr.Camel's Conclusion
This study uncovers the complex interplay between inflammation, NSAIDs, and arachidonic acid metabolism, highlighting the potential for NSAIDs to disrupt the balance of cardiovascular-protective and cardiovascular-toxic metabolites. This research underscores the importance of understanding the nuances of drug-disease interactions and their impact on patient health. The insights gained from this study can help inform the development of safer and more targeted therapies for inflammatory conditions, minimizing the risk of cardiovascular complications.
Date :
- Date Completed 2018-09-11
- Date Revised 2018-12-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.